VIRVir Biotechnology, Inc. insider trades
No insider bought or sold Vir Biotechnology, Inc. (VIR) shares on the open market in the last 90 days. The latest Form 4 transaction on record was filed on Oct 28.
- Market cap
- $1.99B
- as of 2026-10-28
- Latest close
- $11.57
- as of 2026-10-27
- Sector
- Healthcare
- as of 2026-10-28
- Industry
- Biotechnology
- as of 2026-10-28
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-18
Showing the latest 100 of 202 transactions. Search the ledger for VIR
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Topalian Suzanne Louise | Oct 27 | Oct 28 | A | 8,000 | $0.00 | $0 | 8,000 | No | Form 4 |
| Topalian Suzanne Louise | Oct 27 | Oct 28 | A | 4,731 | $0.00 | $0 | 12,731 | No | Form 4 |
| Topalian Suzanne Louise | Oct 27 | Oct 28 | A · derivative | 16,000 | $11.57 | $185,120 | 16,000 | No | Form 4 |
| Topalian Suzanne Louise | Oct 27 | Oct 28 | A · derivative | 9,462 | $11.57 | $109,475 | 25,462 | No | Form 4 |
| More Robert J | Aug 11 | Aug 12 | J | 8,000 | $0.00 | $0 | 40,656 | No | Form 4 |
| More Robert J | Aug 11 | Aug 12 | J | 8,000 | $0.00 | $0 | 517,917 | No | Form 4 |
| Coughlin Timothy | Jun 9 | Jun 10 | A | 8,000 | $0.00 | $0 | 8,000 | No | Form 4 |
| Coughlin Timothy | Jun 9 | Jun 10 | A | 8,000 | $0.00 | $0 | 16,000 | No | Form 4 |
| Coughlin Timothy | Jun 9 | Jun 10 | A · derivative | 16,000 | $8.51 | $136,160 | 16,000 | No | Form 4 |
| Coughlin Timothy | Jun 9 | Jun 10 | A · derivative | 16,000 | $8.51 | $136,160 | 16,000 | No | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Jun 1 | Jun 2 | S | 379 | $9.45 | Sale −$3,582 | 61,902 | Yes | Form 4 |
| Napolitano Janet | Jun 1 | Jun 2 | S | 3,200 | $9.45 | Sale −$30,240 | 21,216 | Yes | Form 4 |
| Bischofberger Norbert W | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 21,333 | No | Form 4 |
| Bischofberger Norbert W | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| Farid Ramy | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 32,000 | No | Form 4 |
| Farid Ramy | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| Hatfield Jeffrey S. | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 39,806 | No | Form 4 |
| Hatfield Jeffrey S. | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| More Robert J | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 48,656 | No | Form 4 |
| More Robert J | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| Napolitano Janet | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 24,416 | No | Form 4 |
| Napolitano Janet | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| Sigal Charles Elliott | May 27 | May 28 | A | 8,000 | $0.00 | $0 | 39,806 | No | Form 4 |
| Sigal Charles Elliott | May 27 | May 28 | A · derivative | 16,000 | $9.10 | $145,600 | 16,000 | No | Form 4 |
| Sato Vicki L | May 1 | May 4 | S | 22,000 | $10.05 | Sale −$221,100 | 1,078,391 | Yes | Form 4 |
| De Backer MariannePresident and CEO | Apr 29 | Apr 30 | J | 233,532 | $0.00 | $0 | 714,613 | No | Form 4 |
| De Backer MariannePresident and CEO | Apr 29 | Apr 30 | J | 233,532 | $0.00 | $0 | 286,650 | No | Form 4 |
| De Backer MariannePresident and CEO | Apr 6 | Apr 7 | S | 72,559 | $9.16 | Sale −$664,640 | 948,145 | Yes | Form 4 |
| Sato Vicki L | Apr 1 | Apr 2 | S | 22,000 | $9.07 | Sale −$199,540 | 1,100,391 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Mar 23 | Mar 24 | S | 7,711 | $9.12 | Sale −$70,324 | 61,902 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Mar 20 | Mar 23 | J | 2,500 | $0.00 | $0 | 160,115 | No | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Mar 20 | Mar 23 | J | 2,500 | $0.00 | $0 | 2,500 | No | Form 4 |
| Sato Vicki L | Mar 2 | Mar 3 | S | 21,800 | $9.50 | Sale −$207,100 | 1,122,591 | Yes | Form 4 |
| Sato Vicki L | Mar 2 | Mar 3 | S | 200 | $9.98 | Sale −$1,996 | 1,122,391 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Feb 25 | Feb 26 | S | 13,700 | $9.82 | Sale −$134,534 | 112,982 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Feb 25 | Feb 26 | S | 1,889 | $9.82 | Sale −$18,550 | 154,024 | Yes | Form 4 |
| De Backer MarianneChief Executive Officer | Feb 24 | Feb 26 | S | 14,762 | $9.53 | Sale −$140,682 | 1,020,704 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Feb 24 | Feb 26 | S | 3,117 | $9.53 | Sale −$29,705 | 126,682 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Feb 24 | Feb 26 | S | 1,616 | $9.53 | Sale −$15,400 | 155,913 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Feb 24 | Feb 26 | S | 1,634 | $9.53 | Sale −$15,572 | 162,615 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Feb 24 | Feb 26 | S | 1,430 | $9.53 | Sale −$13,628 | 69,613 | Yes | Form 4 |
| Sato Vicki L | Feb 24 | Feb 26 | M | 42,377 | $1.49 | $63,142 | 1,186,768 | Yes | Form 4 |
| Sato Vicki L | Feb 24 | Feb 26 | S | 42,177 | $9.75 | Sale −$411,226 | 1,144,591 | Yes | Form 4 |
| Sato Vicki L | Feb 24 | Feb 26 | S | 200 | $10.26 | Sale −$2,052 | 1,144,391 | Yes | Form 4 |
| Sato Vicki L | Feb 24 | Feb 26 | M · derivative | 42,377 | $1.49 | $63,142 | not reported | Yes | Form 4 |
| De Backer MarianneChief Executive Officer | Feb 23 | Feb 24 | S | 19,039 | $7.45 | Sale −$141,841 | 1,035,466 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Feb 23 | Feb 24 | S | 4,445 | $7.45 | Sale −$33,115 | 129,799 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Feb 23 | Feb 24 | S | 2,089 | $7.45 | Sale −$15,563 | 157,529 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Feb 23 | Feb 24 | S | 2,089 | $7.45 | Sale −$15,563 | 164,249 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Feb 23 | Feb 24 | S | 1,829 | $7.45 | Sale −$13,626 | 71,043 | Yes | Form 4 |
| De Backer MarianneChief Executive Officer | Feb 22 | Feb 24 | A | 285,000 | $0.00 | $0 | 1,054,505 | Yes | Form 4 |
| De Backer MarianneChief Executive Officer | Feb 22 | Feb 24 | A · derivative | 570,000 | $7.56 | $4,309,200 | 570,000 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Feb 22 | Feb 24 | A | 55,000 | $0.00 | $0 | 134,244 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Feb 22 | Feb 24 | A · derivative | 110,000 | $7.56 | $831,600 | 110,000 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Feb 22 | Feb 24 | A | 55,000 | $0.00 | $0 | 159,618 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Feb 22 | Feb 24 | A · derivative | 110,000 | $7.56 | $831,600 | 110,000 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Feb 22 | Feb 24 | A | 55,000 | $0.00 | $0 | 166,338 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Feb 22 | Feb 24 | A · derivative | 110,000 | $7.56 | $831,600 | 110,000 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Feb 22 | Feb 24 | A | 25,000 | $0.00 | $0 | 72,872 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Feb 22 | Feb 24 | A · derivative | 50,000 | $7.56 | $378,000 | 50,000 | Yes | Form 4 |
| Sabatini BrentSVP, Chief Accounting Officer | Feb 13 | Feb 18 | S | 1,530 | $7.79 | Sale −$11,919 | 47,872 | Yes | Form 4 |
| Sato Vicki L | Feb 2 | Feb 3 | S | 22,000 | $7.71 | Sale −$169,620 | 1,144,391 | Yes | Form 4 |
| Sato Vicki L | Jan 2 | Jan 5 | S | 22,000 | $5.93 | Sale −$130,460 | 1,166,391 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Dec 1, 2025 | Dec 3, 2025 | S | 191,854 | $5.98 | Sale −$1,147,287 | 13,728,924 | Yes | Form 4 |
| Sato Vicki L | Dec 1, 2025 | Dec 2, 2025 | S | 22,000 | $6.00 | Sale −$132,000 | 1,188,391 | Yes | Form 4 |
| Softbank Vision Fund (Aiv M1) L.P. | Nov 28, 2025 | Dec 1, 2025 | S | 61,493 | $6.44 | Sale −$396,015 | 13,920,778 | Yes | Form 4 |
| Softbank Vision Fund (Aiv M1) L.P. | Nov 26, 2025 | Dec 1, 2025 | S | 127,938 | $6.39 | Sale −$817,524 | 13,982,271 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Nov 25, 2025 | Nov 26, 2025 | S | 235,971 | $6.38 | Sale −$1,505,495 | 14,110,209 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Nov 24, 2025 | Nov 26, 2025 | S | 227,803 | $6.15 | Sale −$1,400,988 | 14,346,180 | Yes | Form 4 |
| O'Byrne JasonEVP & Chief Financial Officer | Nov 17, 2025 | Nov 18, 2025 | S | 6,799 | $5.56 | Sale −$37,802 | 110,701 | Yes | Form 4 |
| de Verneuil VaninaEVP, General Counsel, Corp Sec | Nov 5, 2025 | Nov 7, 2025 | S | 2,385 | $5.16 | Sale −$12,307 | 78,210 | Yes | Form 4 |
| Sato Vicki L | Nov 3, 2025 | Nov 4, 2025 | S | 22,000 | $5.64 | Sale −$124,080 | 1,210,391 | Yes | Form 4 |
| de Verneuil VaninaEVP and General Counsel | Nov 3, 2025 | Nov 4, 2025 | S | 1,365 | $5.86 | Sale −$7,999 | 80,595 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 29, 2025 | Oct 30, 2025 | S | 100 | $6.49 | Sale −$649 | 14,573,983 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 28, 2025 | Oct 30, 2025 | S | 24,453 | $6.50 | Sale −$158,945 | 14,574,083 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 27, 2025 | Oct 28, 2025 | S | 66,403 | $6.05 | Sale −$401,738 | 14,598,536 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 24, 2025 | Oct 28, 2025 | S | 46,696 | $5.96 | Sale −$278,308 | 14,664,939 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 23, 2025 | Oct 24, 2025 | S | 154,383 | $5.99 | Sale −$924,754 | 14,711,635 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 22, 2025 | Oct 24, 2025 | S | 144,266 | $6.15 | Sale −$887,236 | 14,866,018 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 21, 2025 | Oct 22, 2025 | S | 109,675 | $6.30 | Sale −$690,953 | 15,010,284 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 20, 2025 | Oct 22, 2025 | S | 220,535 | $6.20 | Sale −$1,367,317 | 15,119,959 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 16, 2025 | Oct 17, 2025 | S | 12,844 | $6.10 | Sale −$78,348 | 15,340,494 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 15, 2025 | Oct 17, 2025 | S | 16,671 | $6.07 | Sale −$101,193 | 15,353,338 | Yes | Form 4 |
| Softbank Vision Fund (Aiv M1) L.P. | Oct 10, 2025 | Oct 14, 2025 | S | 2,300 | $6.08 | Sale −$13,984 | 15,370,009 | Yes | Form 4 |
| Softbank Vision Fund (Aiv M1) L.P. | Oct 9, 2025 | Oct 14, 2025 | S | 249,060 | $6.14 | Sale −$1,529,228 | 15,372,309 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 8, 2025 | Oct 9, 2025 | S | 466,242 | $6.05 | Sale −$2,820,764 | 15,621,369 | Yes | Form 4 |
| Sb Investment Advisers (Uk) Ltd | Oct 7, 2025 | Oct 9, 2025 | S | 72,133 | $5.60 | Sale −$403,945 | 16,087,611 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 6, 2025 | Oct 7, 2025 | S | 73,955 | $5.69 | Sale −$420,804 | 16,159,744 | Yes | Form 4 |
| SVF Endurance (Cayman) Ltd | Oct 3, 2025 | Oct 7, 2025 | S | 450,342 | $5.56 | Sale −$2,503,902 | 16,233,699 | Yes | Form 4 |
| Sato Vicki L | Oct 1, 2025 | Oct 2, 2025 | S | 22,000 | $5.84 | Sale −$128,480 | 1,232,391 | Yes | Form 4 |
| Sato Vicki L | Sep 2, 2025 | Sep 3, 2025 | S | 22,000 | $4.99 | Sale −$109,780 | 1,254,391 | Yes | Form 4 |
| Sato Vicki L | Aug 1, 2025 | Aug 4, 2025 | S | 22,000 | $4.99 | Sale −$109,780 | 1,276,391 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Jul 17, 2025 | Jul 17, 2025 | S | 3,586 | $5.47 | Sale −$19,615 | 104,618 | Yes | Form 4 |
| Eisner MarkEVP and Chief Medical Officer | Jul 15, 2025 | Jul 17, 2025 | S | 6,796 | $5.47 | Sale −$37,174 | 108,204 | Yes | Form 4 |
| Sato Vicki L | Jul 1, 2025 | Jul 2, 2025 | S | 22,000 | $5.10 | Sale −$112,200 | 1,298,391 | Yes | Form 4 |
| More Robert J | Jun 9, 2025 | Jun 9, 2025 | J | 14,027 | $0.00 | $0 | 40,656 | No | Form 4 |
| More Robert J | Jun 9, 2025 | Jun 9, 2025 | J | 14,027 | $0.00 | $0 | 509,917 | No | Form 4 |
| Bischofberger Norbert W | Jun 6, 2025 | Jun 6, 2025 | J | 10,667 | $0.00 | $0 | 13,333 | No | Form 4 |
| Bischofberger Norbert W | Jun 6, 2025 | Jun 6, 2025 | J | 10,667 | $0.00 | $0 | 10,667 | No | Form 4 |
| Napolitano Janet | Jun 2, 2025 | Jun 2, 2025 | S | 3,200 | $5.05 | Sale −$16,160 | 16,416 | Yes | Form 4 |